Charles Schwab’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,951
Closed -$44K 3583
2025
Q1
$44K Buy
9,951
+5,586
+128% +$36.1K ﹤0.01% 3414
2024
Q4
$30.6K Sell
4,365
-764
-15% -$8.4K ﹤0.01% 3469
2024
Q3
$74.4K Hold
5,129
﹤0.01% 3391
2024
Q2
$374K Sell
5,129
-407
-7% -$31.3K ﹤0.01% 3304
2024
Q1
$328K Hold
5,536
﹤0.01% 3156
2023
Q4
$405K Hold
5,536
﹤0.01% 3153
2023
Q3
$215K Hold
5,536
﹤0.01% 3275
2023
Q2
$319K Buy
+5,536
New +$336K ﹤0.01% 3212
2023
Q1
Sell
-1,257
Closed -$34.6K 3595
2022
Q4
$34.6K Hold
1,257
﹤0.01% 3431
2022
Q3
$37K Buy
+1,257
New +$43.1K ﹤0.01% 3398
2022
Q2
Sell
-3,345
Closed -$272K 3649
2022
Q1
$272K Hold
3,345
﹤0.01% 3240
2021
Q4
$307K Hold
3,345
﹤0.01% 3280
2021
Q3
$419K Buy
3,345
+233
+7% +$26.1K ﹤0.01% 3197
2021
Q2
$352K Hold
3,112
﹤0.01% 3219
2021
Q1
$472K Sell
3,112
-51
-2% -$7.06K ﹤0.01% 3098
2020
Q4
$365K Buy
3,163
+17
+0.5% +$1.56K ﹤0.01% 3094
2020
Q3
$244K Sell
3,146
-233
-7% -$19.1K ﹤0.01% 3120
2020
Q2
$372K Hold
3,379
﹤0.01% 2953
2020
Q1
$370K Buy
3,379
+495
+17% +$65.1K ﹤0.01% 2812
2019
Q4
$459K Sell
2,884
-507
-15% -$74.8K ﹤0.01% 2850
2019
Q3
$501K Buy
3,391
+710
+26% +$79.1K ﹤0.01% 2801
2019
Q2
$312K Buy
2,681
+73
+3% +$6.85K ﹤0.01% 2993
2019
Q1
$282K Buy
2,608
+1,511
+138% +$174K ﹤0.01% 2956
2018
Q4
$90K Hold
1,097
﹤0.01% 3099
2018
Q3
$179K Buy
+1,097
New +$187K ﹤0.01% 3084

Other funds holding VRCA